Active ingredientIbrutinibCat. No. P-I005-001CAS 936563-96-1Family · Pharmaceutical analytical standards
Ibrutinib
An oral inhibitor of Bruton's tyrosine kinase (BTK), an enzyme essential for the survival of B lymphocytes. Approved in the United States in 2013, it is used in chronic lymphocytic leukaemia, mantle cell lymphoma and Waldenström's macroglobulinaemia. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.
Did you know?It was born as a simple laboratory 'tool' for studying BTK: its acrylamide group forms a covalent bond with cysteine 481 of the enzyme, switching it off for a long time.
Go to the active ingredient →Active ingredientIbrutinibCat. No. P-I005-001CAS 936563-96-1
Isotopically labelled(S)-Ibrutinib-d5Cat. No. P-I005-002
Isotopically labelledDihydrodiol Ibrutinib-d5 (Mixture of Diastereomers)Cat. No. P-I005-003CAS 2068022-09-1
Isotopically labelledIbrutinib-d5Cat. No. P-I005-005CAS 1553977-17-5
NitrosamineN-Nitroso Ibrutinib Dimer ImpurityCat. No. P-I005-006
NitrosamineN-Nitroso Ibrutinib Impurity 1Cat. No. P-I005-007
Impurity(S)-1-Benzyl-3-piperidinolCat. No. P-I005-008CAS 91599-79-0
Impurity(S)-IbrutinibCat. No. P-I005-009CAS 936563-97-2
ImpurityIbrutinib Impurity 1Cat. No. P-I005-010CAS 2213398-75-3
ImpurityIbrutinib Impurity 2Cat. No. P-I005-011CAS 2230802-43-2
ImpurityIbrutinib Impurity 3Cat. No. P-I005-012CAS 1092788-11-8
ImpurityIbrutinib deacryloylpiperidineCat. No. P-I005-013CAS 330786-24-8
Impurity4-(Pyridin-2-ylmethoxy)anilineCat. No. P-I005-014CAS 102137-46-2
ImpurityIbrutinib Impurity 4Cat. No. P-I005-015CAS 2134109-10-5
Impurity4-Hydroxy IbrutinibCat. No. P-I005-016CAS 1288339-18-3
Impurity4-PhenoxybenzhydrazideCat. No. P-I005-017CAS 143667-36-1
ImpurityIbrutinib dimerCat. No. P-I005-018CAS 2031255-23-7
ImpurityIbrutinib Dimer 2 (3R) ImpurityCat. No. P-I005-019CAS 2171352-31-9
ImpurityIbrutinib Impurity 5Cat. No. P-I005-021CAS 1022150-11-3
ImpurityIbrutinib Impurity 6Cat. No. P-I005-022
ImpurityIbrutinib Impurity 6 HydrochlorideCat. No. P-I005-023
ImpurityIbrutinib Impurity 7Cat. No. P-I005-024CAS 1839099-22-7
ImpurityIbrutinib Impurity 8Cat. No. P-I005-025CAS 2417548-76-4
ImpurityIbrutinib Impurity 10Cat. No. P-I005-027
ImpurityIbrutinib Impurity 11Cat. No. P-I005-028CAS 1022150-12-4
ImpurityIbrutinib Impurity 12Cat. No. P-I005-030CAS 2031255-27-1
ImpurityIbrutinib Impurity 14Cat. No. P-I005-034CAS 1917333-91-5
ImpurityIbrutinib Impurity 15Cat. No. P-I005-035CAS 1642630-12-3
ImpurityIbrutinib Impurity 16Cat. No. P-I005-037
ImpurityIbrutinib Impurity 17Cat. No. P-I005-040CAS 1288338-95-3
ImpurityIbrutinib Impurity 18Cat. No. P-I005-042
ImpurityIbrutinib Impurity 19 (Mixture of Diastereomers)Cat. No. P-I005-043CAS 1654820-87-7
ImpurityIbrutinib Impurity 20Cat. No. P-I005-044CAS 2540665-98-1
ImpurityIbrutinib Impurity 21Cat. No. P-I005-045
ImpurityIbrutinib Impurity 22Cat. No. P-I005-047
ImpurityIbrutinib Impurity 23 (Mixture of Diastereomers)Cat. No. P-I005-049
ImpurityIbrutinib Impurity 24Cat. No. P-I005-050
ImpurityIbrutinib Impurity 25Cat. No. P-I005-051CAS 2064175-45-5
ImpurityIbrutinib Impurity 26Cat. No. P-I005-053CAS 2417548-74-2
ImpurityIbrutinib Impurity 27Cat. No. P-I005-054
ImpurityIbrutinib Impurity 28Cat. No. P-I005-055
ImpurityIbrutinib Impurity 29Cat. No. P-I005-056CAS 1612774-29-4
ImpurityIbrutinib Impurity 30Cat. No. P-I005-057
ImpurityIbrutinib Impurity 31Cat. No. P-I005-058
ImpurityIbrutinib Impurity 32Cat. No. P-I005-059CAS 1838132-94-7
ImpurityIbrutinib Impurity 33Cat. No. P-I005-060CAS 1288338-96-4
ImpurityIbrutinib Impurity 34Cat. No. P-I005-061CAS 2031255-24-8
ImpurityIbrutinib Impurity 35Cat. No. P-I005-062
ImpurityIbrutinib Impurity 36Cat. No. P-I005-063
ImpurityIbrutinib Impurity 37Cat. No. P-I005-064
ImpurityIbrutinib Impurity 38Cat. No. P-I005-065
ImpurityIbrutinib Impurity 39Cat. No. P-I005-066CAS 1638583-50-2
ImpurityIbrutinib Impurity 40Cat. No. P-I005-067CAS 1987905-93-0
ImpurityIbrutinib Impurity 41Cat. No. P-I005-068CAS 1839099-36-3
ImpurityIbrutinib Impurity 42Cat. No. P-I005-070CAS 2417548-83-3
ImpurityIbrutinib M25Cat. No. P-I005-071CAS 1839090-60-6
ImpurityIbrutinib Methoxy ImpurityCat. No. P-I005-072CAS 2031255-26-0
ImpurityIbrutinib N-Desacryloyl N-(3-Acryloyl-propanoyl)Cat. No. P-I005-073CAS 2244619-11-0
ImpurityIbrutinib N1-OxideCat. No. P-I005-076CAS 2437254-47-0
ImpurityIbrutinib N2-OxideCat. No. P-I005-077CAS 2052279-49-7
ImpurityN-Boc-(S)-IbrutinibCat. No. P-I005-078CAS 1642571-08-1
ImpurityN1,N6 (S)-IbrutinibCat. No. P-I005-079CAS 2417548-77-5
Impurityrac-IbrutinibCat. No. P-I005-081CAS 936563-87-0
ImpurityIbrutinib Impurity 44Cat. No. P-I005-082CAS 936563-92-7
ImpurityIbrutinib Interm 0441Cat. No. P-I005-083CAS 143900-44-1No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.